Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Heart failure AND skeletal muscle AND wasting AND cachexia:

Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016. Saitoh M et al. Int J Cardiol. (2017)

Muscle wasting and sarcopenia in heart failure and beyond: update 2017. Springer J et al. ESC Heart Fail. (2017)

The wasting continuum in heart failure: from sarcopenia to cachexia. von Haehling S et al. Proc Nutr Soc. (2015)

Search results

Items: 1 to 20 of 183

1.

Skeletal muscle wasting in chronic heart failure.

Suzuki T, Palus S, Springer J.

ESC Heart Fail. 2018 Dec 7. doi: 10.1002/ehf2.12387. [Epub ahead of print] Review.

PMID:
30548178
2.

Iron deficiency as energetic insult to skeletal muscle in chronic diseases.

Dziegala M, Josiak K, Kasztura M, Kobak K, von Haehling S, Banasiak W, Anker SD, Ponikowski P, Jankowska E.

J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):802-815. doi: 10.1002/jcsm.12314. Epub 2018 Sep 4. Review.

3.

Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure.

Tsuda M, Fukushima A, Matsumoto J, Takada S, Kakutani N, Nambu H, Yamanashi K, Furihata T, Yokota T, Okita K, Kinugawa S, Anzai T.

J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):844-859. doi: 10.1002/jcsm.12322. Epub 2018 Aug 30.

4.

Skeletal muscle-gut axis: emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases.

de Sire R, Rizzatti G, Ingravalle F, Pizzoferrato M, Petito V, Lopetuso L, Graziani C, de Sire A, Mentella MC, Mele MC, Gasbarrini A, Scaldaferri F.

Minerva Gastroenterol Dietol. 2018 Dec;64(4):351-362. doi: 10.23736/S1121-421X.18.02511-4. Epub 2018 Jul 18.

PMID:
30016852
5.

Role of defective Ca2+ signaling in skeletal muscle weakness: Pharmacological implications.

Agrawal A, Suryakumar G, Rathor R.

J Cell Commun Signal. 2018 Dec;12(4):645-659. doi: 10.1007/s12079-018-0477-z. Epub 2018 Jul 7. Review.

6.

Muscle atrophy in chronic obstructive pulmonary disease: molecular basis and potential therapeutic targets.

Barreiro E, Jaitovich A.

J Thorac Dis. 2018 May;10(Suppl 12):S1415-S1424. doi: 10.21037/jtd.2018.04.168. Review.

7.

Associations of pre-existing co-morbidities with skeletal muscle mass and radiodensity in patients with non-metastatic colorectal cancer.

Xiao J, Caan BJ, Weltzien E, Cespedes Feliciano EM, Kroenke CH, Meyerhardt JA, Baracos VE, Kwan ML, Castillo AL, Prado CM.

J Cachexia Sarcopenia Muscle. 2018 Aug;9(4):654-663. doi: 10.1002/jcsm.12301. Epub 2018 Apr 19.

8.

[Cachexia and sarcopenia in chronic heart failure : Change in muscle strength and muscle structure].

Ebner N, von Haehling S.

Internist (Berl). 2018 May;59(5):439-444. doi: 10.1007/s00108-018-0408-3. Review. German.

PMID:
29637239
9.

Depleted iron stores are associated with inspiratory muscle weakness independently of skeletal muscle mass in men with systolic chronic heart failure.

Tkaczyszyn M, Drozd M, Węgrzynowska-Teodorczyk K, Flinta I, Kobak K, Banasiak W, Ponikowski P, Jankowska EA.

J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):547-556. doi: 10.1002/jcsm.12282. Epub 2018 Mar 23.

11.

Is Exercise Training Appropriate for Patients With Advanced Heart Failure Receiving Continuous Inotropic Infusion? A Review.

Amiya E, Taya M.

Clin Med Insights Cardiol. 2018 Jan 3;12:1179546817751438. doi: 10.1177/1179546817751438. eCollection 2018. Review.

12.

Effect of sarcopenia on clinical and surgical outcome in elderly patients with proximal femur fractures.

Chang CD, Wu JS, Mhuircheartaigh JN, Hochman MG, Rodriguez EK, Appleton PT, Mcmahon CJ.

Skeletal Radiol. 2018 Jun;47(6):771-777. doi: 10.1007/s00256-017-2848-6. Epub 2017 Dec 15.

PMID:
29247259
13.

Sex Differences in Muscle Wasting.

Anderson LJ, Liu H, Garcia JM.

Adv Exp Med Biol. 2017;1043:153-197. doi: 10.1007/978-3-319-70178-3_9. Review.

PMID:
29224095
14.

Cardiac muscle wasting in individuals with cancer cachexia.

Barkhudaryan A, Scherbakov N, Springer J, Doehner W.

ESC Heart Fail. 2017 Nov;4(4):458-467. doi: 10.1002/ehf2.12184. Epub 2017 Jul 15.

15.

Muscle wasting and sarcopenia in heart failure and beyond: update 2017.

Springer J, Springer JI, Anker SD.

ESC Heart Fail. 2017 Nov;4(4):492-498. doi: 10.1002/ehf2.12237. Review.

16.

Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure.

Barazzoni R, Gortan Cappellari G, Palus S, Vinci P, Ruozi G, Zanetti M, Semolic A, Ebner N, von Haehling S, Sinagra G, Giacca M, Springer J.

J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):991-998. doi: 10.1002/jcsm.12254. Epub 2017 Nov 3.

17.

Quantitative assessment of muscle in dogs using a vertebral epaxial muscle score.

Freeman LM, Sutherland-Smith J, Prantil LR, Sato AF, Rush JE, Barton BA.

Can J Vet Res. 2017 Oct;81(4):255-260.

18.

The need for both animal models and clinical trials in cachexia, but is a man more like a mouse than another man?

Stewart Coats AJ.

Int J Cardiol. 2018 Apr 1;256:36. doi: 10.1016/j.ijcard.2017.08.032. Epub 2017 Aug 14. No abstract available.

PMID:
28939269
19.

New insights about the putative role of myokines in the context of cardiac rehabilitation and secondary cardiovascular prevention.

Di Raimondo D, Miceli G, Musiari G, Tuttolomondo A, Pinto A.

Ann Transl Med. 2017 Aug;5(15):300. doi: 10.21037/atm.2017.07.30. Review.

20.

Integration of miRNA and mRNA expression profiles reveals microRNA-regulated networks during muscle wasting in cardiac cachexia.

Moraes LN, Fernandez GJ, Vechetti-Júnior IJ, Freire PP, Souza RWA, Villacis RAR, Rogatto SR, Reis PP, Dal-Pai-Silva M, Carvalho RF.

Sci Rep. 2017 Aug 1;7(1):6998. doi: 10.1038/s41598-017-07236-2.

Supplemental Content

Loading ...
Support Center